- Home
- ABLV vs BRNS Comparison
ABLV vs BRNS Comparison
Compare ABLV & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- BRNS
- Stock Information
- Founded
- ABLV 2015
- BRNS 2016
- Country
- ABLV China
- BRNS United Kingdom
- Employees
- ABLV N/A
- BRNS N/A
- Industry
- ABLV
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ABLV
- BRNS Health Care
- Exchange
- ABLV Nasdaq
- BRNS Nasdaq
- Market Cap
- ABLV 38.1M
- BRNS 36.7M
- IPO Year
- ABLV N/A
- BRNS 2021
- Fundamental
- Price
- ABLV $0.65
- BRNS $1.04
- Analyst Decision
- ABLV
- BRNS Strong Buy
- Analyst Count
- ABLV 0
- BRNS 2
- Target Price
- ABLV N/A
- BRNS $4.00
- AVG Volume (30 Days)
- ABLV 18.1K
- BRNS 59.3K
- Earning Date
- ABLV 01-01-0001
- BRNS 11-06-2024
- Dividend Yield
- ABLV N/A
- BRNS N/A
- EPS Growth
- ABLV 18.07
- BRNS N/A
- EPS
- ABLV 0.24
- BRNS N/A
- Revenue
- ABLV $148,999,819.00
- BRNS $14,969,000.00
- Revenue This Year
- ABLV N/A
- BRNS $1,805.74
- Revenue Next Year
- ABLV N/A
- BRNS N/A
- P/E Ratio
- ABLV $3.07
- BRNS N/A
- Revenue Growth
- ABLV 2.58
- BRNS 106.21
- 52 Week Low
- ABLV $0.55
- BRNS $0.80
- 52 Week High
- ABLV $3.94
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- ABLV 45.41
- BRNS 50.96
- Support Level
- ABLV $0.55
- BRNS $0.80
- Resistance Level
- ABLV $0.77
- BRNS $1.05
- Average True Range (ATR)
- ABLV 0.07
- BRNS 0.13
- MACD
- ABLV -0.01
- BRNS 0.02
- Stochastic Oscillator
- ABLV 48.83
- BRNS 54.44
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.